GCG and obesity due to melanocortin 4 receptor deficiency: As such, glucagon infusions were initially posited as a therapeutic anti‐obesity tool,3 although this is not practical due to significant health risks associated with glucagon‐mediated, enhanced release of fatty acids, hypoaminoacidaemia, uraemia, and muscle wasting.2